NCT07045948Recruiting
Biannual Review of Exhaled Air and Trends in Health Evaluation in COPD
Source: ClinicalTrials.gov · Last updated 11 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study aims to evaluate how airway inflammation, lung function, and symptoms change over time in people with chronic obstructive pulmonary disease (COPD). Airway inflammation will be assessed using a simple breath test (FeNO) and a small blood sample to measure eosinophils, a type of white blood cell. Participants will be followed for one year, with three study visits (at the start, 6 months, and 12 months). The goal is to understand how these markers evolve and whether they differ between people who experience a worsening of symptoms (called exacerbations) and those who remain stable. All tests except for a small extra blood draw are part of routine COPD care. Participation does not affect standard treatment.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- First submitted
- 23 Jun 2025
- Start date
- 14 Jul 2025
- Primary completion date
- 30 Jun 2027
- Lead sponsor
- Universitair Ziekenhuis Brussel
- Diseases
- COPD
- NCT number
- NCT07045948
What you commit to
- Study type: Interventional
- Planned participants: 100
- From 14 Jul 2025 to the primary completion date, 30 Jun 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Recent respiratory tract infection or exacerbation (either moderate or se-vere) (\<4 weeks before inclusion)
Other
- Dominant asthmatic phenotype (ACO with asthma predominance)
- Severe comorbidities interfering with participation or follow-up
Who the study is looking for
- Adults aged ≥ 40 years
- Diagnosed with COPD according to GOLD criteria
- Attending routine follow-up visits every 6 months
- Ability to provide informed consent
Age in the registry: 40 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Universitair Ziekenhuis Brussel Coordinator of this site? Confirm its status | Jette | Belgium | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.